ESAR - European Surveillance of Antibiotic Resistance
All Alert isolates
Alert Organisms by phenotype, Total and Percent resistant

Year = 1999
  All centers Aberdeen Leipzig Bratislava (St. El.) Bratislava (NCI) Warsaw
Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant
N % N % N % N % N % N %
Organism Phenotype 7914 105 1.33 3991 55 1.38 299 3 1.00 130 4 3.08 3276 37 1.13 218 6 2.75
Beta-haemolytic Streptococci Macrolide
Glycopeptide 7914 1 0.01 3991 0 0.00 299 1 0.33 130 0 0.00 3276 0 0.00 218 0 0.00
Penicillin 7914 4 0.05 3991 0 0.00 299 3 1.00 130 0 0.00 3276 1 0.03 218 0 0.00
Pneumococci Macrolide 3249 48 1.48 593 10 1.69 39 1 2.56 8 1 12.50 2476 30 1.21 133 6 4.51
Glycopeptide 3249 0 0.00 593 0 0.00 39 0 0.00 8 0 0.00 2476 0 0.00 133 0 0.00
High level Penicllin 3249 2 0.06 593 0 0.00 39 0 0.00 8 0 0.00 2476 1 0.04 133 1 0.75
Low level Penicillin 3249 101 3.11 593 2 0.34 39 0 0.00 8 1 12.50 2476 80 3.23 133 18 13.53
Enterococci Beta-lactamase positive 11801 86 0.73 5360 0 0.00 895 48 5.36 181 5 2.76 5074 28 0.55 291 5 1.72
Glycopeptide 11801 12 0.10 5360 0 0.00 895 2 0.22 181 1 0.55 5074 1 0.02 291 8 2.75
High level aminoglycoside 11801 367 3.11 5360 0 0.00 895 203 22.68 181 7 3.87 5074 63 1.24 291 94 32.30
Haemophilus Beta-lactamase positive 5550 87 1.57 1046 22 2.10 137 0 0.00 60 1 1.67 4268 61 1.43 39 3 7.69
Ceftazidime/3rd or 4th generation cephalosporin 5550 0 0.00 1046 0 0.00 137 0 0.00 60 0 0.00 4268 0 0.00 39 0 0.00
Ciprofloxacin/4-fluoroquinolone 5550 0 0.00 1046 0 0.00 137 0 0.00 60 0 0.00 4268 0 0.00 39 0 0.00
Enterobacteriaceae Carbapenem 49393 10 0.02 27099 2 0.01 2162 8 0.37 758 0 0.00 18174 0 0.00 1200 0 0.00
Ciprofloxacin/4-fluoroquinolone 49393 922 1.87 27099 319 1.18 2162 106 4.90 758 25 3.30 18174 394 2.17 1200 78 6.50
Extended spectrum beta-lactamase positive 49393 280 0.57 27099 0 0.00 2162 62 2.87 758 10 1.32 18174 149 0.82 1200 59 4.92
Gentamicin 49393 898 1.82 27099 77 0.28 2162 85 3.93 758 16 2.11 18174 609 3.35 1200 111 9.25
Acinetobacter Carbapenem 1990 7 0.35 436 0 0.00 140 5 3.57 34 0 0.00 1280 0 0.00 100 2 2.00
Gentamicin 1990 277 13.92 436 1 0.23 140 10 7.14 34 3 8.82 1280 224 17.50 100 39 39.00
Staphylococcus aureaus Total Methicillin 29789 830 2.79 14033 625 4.45 989 17 1.72 209 2 0.96 13745 116 0.84 813 70 8.61
Teicoplanin 29789 0 0.00 14033 0 0.00 989 0 0.00 209 0 0.00 13745 0 0.00 813 0 0.00
Vancomycin 29789 1 0.00 14033 0 0.00 989 1 0.10 209 0 0.00 13745 0 0.00 813 0 0.00
Cholera Tetracycline/Doxycycline 8 0 0.00 0 0 - 0 0 - 0 0 - 8 0 0.00 0 0 -
Trimethoprim 8 0 0.00 0 0 - 0 0 - 0 0 - 8 0 0.00 0 0 -
Campylobacter Ciprofloxacin 912 105 11.51 749 105 14.02 5 0 0.00 0 0 - 154 0 0.00 4 0 0.00
Shigella Ciprofloxacin 121 0 0.00 18 0 0.00 3 0 0.00 0 0 - 100 0 0.00 0 0 -
Salmonella Ciprofloxacin 1906 0 0.00 335 0 0.00 39 0 0.00 5 0 0.00 1527 0 0.00 0 0 -
Neisseria meningitidis Penicillin 83 0 0.00 33 0 0.00 0 0 - 0 0 - 20 0 0.00 30 0 0.00
Neisseria gonorrhoea Beta-lactamase positive 98 4 4.08 84 3 3.57 1 0 0.00 0 0 - 13 1 7.69 0 0 -
Ciprofloxacin/4-fluoroquinolone 98 4 4.08 84 4 4.76 1 0 0.00 0 0 - 13 0 0.00 0 0 -
Anaerobes Augmentin/beta-lactamase inhibitor combination 8074 6 0.07 6773 6 0.09 228 0 0.00 39 0 0.00 1034 0 0.00 0 0 -
Carbapenem 8074 0 0.00 6773 0 0.00 228 0 0.00 39 0 0.00 1034 0 0.00 0 0 -
Metronidazole 8074 8 0.10 6773 0 0.00 228 0 0.00 39 4 10.26 1034 4 0.39 0 0 -
Coagulase negative Staphylococci Teicoplanin 8344 3 0.04 3599 0 0.00 676 3 0.44 234 0 0.00 3835 0 0.00 0 0 -
Vancomycin 8344 1 0.01 3599 0 0.00 676 0 0.00 234 0 0.00 3835 1 0.03 0 0 -
Pseudomonas aeruginosa Ceftazidime/4th generation cephalosporin 7351 227 3.09 2259 25 1.11 578 21 3.63 89 1 1.12 4245 167 3.93 180 13 7.22
Gentamicin 7351 835 11.36 2259 50 2.21 578 77 13.32 89 14 15.73 4245 650 15.31 180 44 24.44
Piperacillin/Tazobactam 7351 259 3.52 2259 13 0.58 578 23 3.98 89 1 1.12 4245 205 4.83 180 17 9.44

ESBiC Study Center